Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes I Vitry

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Diabetes Care|June 6, 2013
Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complicationsGillian E Caughey, Adrian K Preiss, Agnes I Vitry, et al.
International Journal of Rheumatic Diseases|July 16, 2015
Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomideAshley M Hopkins, Agnes I Vitry, Catherine E O'Doherty, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2010
Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?Gillian E Caughey, Elizabeth E Roughead, Nicole Pratt, et al.
Age and Ageing|June 1, 2010
Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressantsGillian Elizabeth Caughey, Elizabeth Ellen Roughead, Sepehr Shakib, et al.
Diabetes Research and Clinical Practice|November 20, 2009
Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflictsGillian E Caughey, Elizabeth E Roughead, Agnes I Vitry, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|July 10, 2009
Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular diseaseElizabeth E Roughead, Agnes I Vitry, Adrian Kym Preiss, et al.
Plos Medicine|October 27, 2010
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic reviewGeoffrey K Spurling, Peter R Mansfield, Brett D Montgomery, et al.
The Medical Journal of Australia|January 29, 2016
Ten years of publicly funded biological disease-modifying antirheumatic drugs in AustraliaAshley M Hopkins, Susanna M Proudman, Agnes I Vitry, et al.
Australian Health Review : a Publication of the Australian Hospital Association|October 16, 2012
Chronic disease management: does the disease affect likelihood of care planning?Agnes I Vitry, Elizabeth E Roughead, Emmae N Ramsay, et al.
Pharmacoepidemiology and Drug Safety|March 1, 2013
Does antidepressant medication use affect persistence with diabetes medicines?Gillian E Caughey, Adrian K Preiss, Agnes I Vitry, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Diabetes Care|June 6, 2013
Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complicationsGillian E Caughey, Adrian K Preiss, Agnes I Vitry, et al.
International Journal of Rheumatic Diseases|July 16, 2015
Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomideAshley M Hopkins, Agnes I Vitry, Catherine E O'Doherty, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2010
Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?Gillian E Caughey, Elizabeth E Roughead, Nicole Pratt, et al.
Age and Ageing|June 1, 2010
Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressantsGillian Elizabeth Caughey, Elizabeth Ellen Roughead, Sepehr Shakib, et al.
Diabetes Research and Clinical Practice|November 20, 2009
Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflictsGillian E Caughey, Elizabeth E Roughead, Agnes I Vitry, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|July 10, 2009
Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular diseaseElizabeth E Roughead, Agnes I Vitry, Adrian Kym Preiss, et al.
Plos Medicine|October 27, 2010
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic reviewGeoffrey K Spurling, Peter R Mansfield, Brett D Montgomery, et al.
The Medical Journal of Australia|January 29, 2016
Ten years of publicly funded biological disease-modifying antirheumatic drugs in AustraliaAshley M Hopkins, Susanna M Proudman, Agnes I Vitry, et al.
Australian Health Review : a Publication of the Australian Hospital Association|October 16, 2012
Chronic disease management: does the disease affect likelihood of care planning?Agnes I Vitry, Elizabeth E Roughead, Emmae N Ramsay, et al.
Pharmacoepidemiology and Drug Safety|March 1, 2013
Does antidepressant medication use affect persistence with diabetes medicines?Gillian E Caughey, Adrian K Preiss, Agnes I Vitry, et al.
Pageof 4